Hexarelin – 3mg Research Compound

Hexarelin — Research Compound

Hexarelin is a synthetic peptide known as a growth hormone secretagogue, meaning it signals the body to naturally release its own growth hormone. Engineered as a powerful analogue in the GHRP family, it is distinct for its dual action on both hormone signalling and cardiovascular pathways. In laboratory settings, it is investigated primarily for its role in cellular recovery, muscle preservation, and heart tissue protection.

Findings from early-stage clinical trials have reported:

• Rapid and potent stimulation of natural growth hormone release in experimental models.
• Direct protective effects on heart muscle tissue and resilience against cardiovascular stress.
• Support for lean tissue preservation and cellular repair mechanisms.
• Positive modulation of metabolic markers and systemic recovery pathways.

Researchers study Hexarelin to explore the biological pathways involved in natural hormone production, tissue rejuvenation, and cardiovascular strength, with particular interest in its potential relevance to heart health, physical recovery, and cellular protection.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

References

Growth Hormone-Releasing Activity of Hexarelin in Humans: A Dose-Response Study
This double-blind, placebo-controlled human study examined Hexarelin and demonstrated potent, dose-dependent stimulation of growth hormone secretion in healthy adult volunteers.
Source Link: Available here

Growth Hormone-Releasing Activity of Hexarelin, a New Synthetic Hexapeptide, After Intravenous, Subcutaneous, Intranasal, and Oral Administration in Man
This human study investigated the growth hormone-releasing activity of Hexarelin across several administration routes and reported a strong, dose-dependent growth hormone response.
Source Link: Available here

The Cardiovascular Action of Hexarelin
This scientific review examines research into Hexarelin’s cardiovascular activity, including growth hormone-independent pathways, cardiac receptors, cardiomyocyte survival, and experimental cardioprotective effects.
Source Link: Available here

Hexarelin Protects H9c2 Cardiomyocytes from Doxorubicin-Induced Cell Death
This preclinical study investigated Hexarelin in cultured cardiomyocytes and reported evidence of increased cell survival and reduced experimentally induced apoptosis, supporting further investigation of its cardiac cellular effects.
Source Link: Available here

Certificate of Analysis (COA): Available here